LONDON, UK / ACCESSWIRE / July 15, 2022 / Roquefort Therapeutics (LSE:ROQ), the Main Market listed biotech company focused on early-stage opportunities in the biotechnology sector, is pleased to announce that trading in the Company's Ordinary Shares of one pence each ("Ordinary Shares") has commenced on the OTCQB Venture Market in the United States. The Company's OTCQB shares have the ticker: ROQAF There is no associated capital raise with this cross trading and Roquefort Therapeutics's Ordinary...